Targeting ER stress induced apoptosis and inflammation in cancer

T Verfaillie, AD Garg, P Agostinis - Cancer letters, 2013 - Elsevier
Disturbance in the folding capacity of the endoplasmic reticulum (ER), caused by a variety of
endogenous and exogenous insults, prompts a cellular stress condition known as ER stress …

Targeting Mcl-1 for the therapy of cancer

BA Quinn, R Dash, B Azab, S Sarkar… - Expert opinion on …, 2011 - Taylor & Francis
Introduction: Human cancers are genetically and epigenetically heterogeneous and have
the capacity to commandeer a variety of cellular processes to aid in their survival, growth …

T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions

T Oka, SS Smith, HG Son, T Lee, VS Oliver-Garcia… - The Journal of Clinical …, 2025 - jci.org
The continuous rise in skin cancer incidence highlights an imperative for improved skin
cancer prevention. Topical calcipotriol-plus–5-fluorouracil (calcipotriol-plus–5-FU) …

Targeting the unfolded protein response in cancer

R Ojha, RK Amaravadi - Pharmacological research, 2017 - Elsevier
Cancer cells are exposed to various intrinsic and extrinsic factors that disrupt protein
homeostasis, producing endoplasmic reticulum (ER) stress. To cope with these situations …

The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma

NMP Fajardo, C Meijer, FAE Kruyt - Biochemical pharmacology, 2016 - Elsevier
Endoplasmic reticulum (ER) stress disrupts among others protein homeostasis in cells
leading to the activation of the unfolded protein response (UPR) that is crucial for restoring …

Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks

Z Li, Z Li - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2012 - Elsevier
Glucose regulated protein 78 (GRP78) has long been recognized as a molecular chaperone
in the endoplasmic reticulum (ER) and can be induced by the ER stress response. Besides …

MDA-7/IL-24: multifunctional cancer killing cytokine

ME Menezes, S Bhatia, P Bhoopathi, SK Das… - Anticancer Genes, 2014 - Springer
First identified almost two decades ago as a novel gene differentially expressed in human
melanoma cells induced to terminally differentiate, MDA-7/IL-24 has since shown great …

The molecular chaperone GRP78/BiP in the development of chemoresistance: mechanism and possible treatment

C Roller, D Maddalo - Frontiers in pharmacology, 2013 - frontiersin.org
Treatment of several types of cancer such as lung, breast, prostate, and pancreas has
shown notable progresses in the past decades. However, after an initial response, tumors …

Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24–mediated toxicity

R Dash, B Azab, BA Quinn, X Shen… - Proceedings of the …, 2011 - National Acad Sciences
Limited options are available for treating patients with advanced prostate cancer (PC).
Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), an IL-10 family …

Mechanism of action and applications of interleukin 24 in immunotherapy

L Persaud, D De Jesus, O Brannigan… - International journal of …, 2016 - mdpi.com
Interleukin 24 (IL-24) is an important pleiotropic immunoregulatory cytokine, whose gene is
located in human chromosome 1q32-33. IL-24's signaling pathways have diverse biological …